NCT07512934 Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
| NCT ID | NCT07512934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West Kazakhstan Marat Ospanov Medical University |
| Condition | Pancreatogenic Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 310 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 310 participants in total. It began in 2025-07-07 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to better understand how the pancreas works in adults with type 2 diabetes. The study focuses on both hormone production (endocrine function) and digestive function (exocrine function) of the pancreas. The main questions it aims to answer are: * Can problems with the pancreas help identify a different type of diabetes called pancreatogenic diabetes? * How are blood markers and pancreas structure related to pancreatic function? Participants will: * Have blood tests to measure glucose, insulin, and other markers * Provide a stool sample to assess digestive function * Undergo an ultrasound examination of the pancreas * Answer questions about digestive symptoms The study will take place during a single visit in outpatient clinics.
Eligibility Criteria
Inclusion Criteria: * • adult patients of Kazakh nationality aged 18 to 74 years * diagnosis of T2DM established according to ADA criteria and documented in medical records * disease duration ≤5 years * absence of ketoacidosis episodes within the last 6 months Exclusion Criteria: * positive anti-glutamic acid decarboxylase antibodies (anti-GAD65); * acute or chronic infections affecting metabolic status within the previous 4 weeks; * any history of malignant neoplasms; * pregnancy or lactation; * previously diagnosed type 1 diabetes mellitus or other specific types of diabetes; * severe decompensated chronic diseases; * conditions associated with systemic fibrosis (e.g., liver cirrhosis or autoimmune diseases); * refusal to participate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07512934 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 74 Years, studying Pancreatogenic Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07512934 currently recruiting?
Yes, NCT07512934 is actively recruiting participants. Contact the research team at ersultanbeknur@gmail.com for enrollment information.
Where is the NCT07512934 trial being conducted?
This trial is being conducted at Aktobe, Kazakhstan.
Who is sponsoring the NCT07512934 clinical trial?
NCT07512934 is sponsored by West Kazakhstan Marat Ospanov Medical University. The trial plans to enroll 310 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.